Neutral 16 Sep, 21:30 Impact +5

AstraZeneca Invests $2.5 Billion in Research Center in Beijing

Positive 4 Sep, 20:41 Impact +9

AstraZeneca's Model Expected to Launch Post-September 25 with High Probability

Neutral 31 Aug, 08:17 Impact +5

Fire Breaks Out at Surgutneftegas Kirishi Refinery Following Drone Attack

Negative 27 Aug, 05:08 Impact +5

Akeso's Ivonescimab Outperforms AstraZeneca's Imfinzi in Phase 3 Trial for Biliary Tract Cancer

Earnings 26 Aug, 14:56 Impact +5

AstraZeneca Reports Strong Q2 2026 Results with Improved Profitability and Controlled Expenses

Earnings 26 Aug, 09:48 Impact +5

AstraZeneca Reports Strong H1 Results with Revenue Up 17%

Earnings 26 Aug, 09:02 Impact +5

AstraZeneca Reports 47% Revenue Growth for Q2 2026

Regulatory 12 Aug, 15:04 Impact 0

Orexin drugs emerge as a potential growth area beyond narcolepsy

Regulatory 12 Aug, 15:03 Impact 0

Orexin drugs emerge as a potential growth area beyond narcolepsy

M&A 5 Aug, 15:33 Impact +5

AstraZeneca and Bristol Myers Not in Merger Talks, Clarifies RTRS

Neutral 5 Aug, 12:51 Impact +5

Moscow Exchange Conducts Discrete Auction for AstraZeneca Shares

M&A 3 Aug, 22:29 Impact +5

AstraZeneca and Bristol-Myers Squibb in Preliminary Merger Talks, Potential Value at $400 Billion

M&A 2 Aug, 23:10 Impact +5

AstraZeneca and Bristol Myers Discuss Potential Merger Valued Over $400 Billion

Neutral 27 Jul, 06:55 Impact +5

AstraZeneca Earnings Report Scheduled for July 27, 2026